Aim: To assess whether or not visual evoked potentials (VEPs) are abnormal in konzo, a para/tetraparesis of sudden onset, and to correlate the findings to the clinical picture of the disorder. Methods: VEPs were recorded in 23 patients (9 men and 14 women, mean age: 23 ± 10 years) suffering from konzo, and 38 healthy subjects (20 men and 18 women, mean age: 27 ± 15 years). The mean P100 latencies and peak-to-peak N75-P100 amplitudes of each eye were measured and compared in the two groups. The mean interocular P100 latency and amplitude differences were calculated and also compared. Results: VEPs were abnormal in 11/23 patients (48%) consisting of P100 prolongation (7 subjects), absence of P100 wave (2 subjects) or an atypical waveform (2 subjects). The mean P100 latency value of the konzo group was significantly increased as compared with the mean (+ 2.5 SD) of the reference values from healthy subjects (p < 0.05). There was a statistically significant decrease of amplitude in konzo patients compared to normal subjects (p < 0.05) with, however, only 2 patients outside the 95% confidence limits. Six patients (27%) had abnormal VEPs despite normal visual acuity. These abnormalities were symmetric and a relation could be found between neither the duration nor the severity of the disease and the VEP perturbation. Conclusion: The main features of these abnormalities are delayed P100 latency and decreased amplitude. These findings indicate involvement of visual pathways and seem to suggest the presence of axonal loss in the prechiasmal visual pathways in konzo. This study provides evidence that the neurodamage in konzo extends to the visual pathways.

Keywords:
Konzo, Upper motor neuron, Visual evoked potential
1.
Tylleskär T, Légué F, Peterson S, Kpizingui E, Stecker P: Konzo in the Central African Republic. Neurology 1994;44:959–961.
2.
Tylleskär T, Banea M, Bikangi N, Cooke RD, Poulter NH, Rosling H: Cassava cyanogens and konzo, an upper motorneuron disease found in Africa. Lancet 1992;339:208–211.
3.
Ministry of Health Mozambique: Mantakassa: An epidemic of spastic paraparesis associated with chronic cyanide intoxication in a cassava staple area in Mozambique. 1. Epidemiology and clinical and laboratory findings in patients. Bull World Health Organ 1984;62:477–484.
4.
Howlett WP, Brubaker GR, Mlingi N, Rosling H: Konzo, an epidemic upper motor neuron disease studied in Tanzania. Brain 1990;113:223–235.
5.
Trolli G: Paraplégie spastique épidémique, ‘Konzo’ des indigènes du Kwango; in Trolli G (ed): Résumé des observations réunies, au Kwango, au sujet de deux affections d’origine indéterminée. Brussels, Fonds Reine Elisabeth, 1938, pp 1–36.
6.
Tshala-Katumbay D, Eeg-Olofsson KE, Tylleskär T, Kazadi-Kayembe T: Impairments, disabilities and handicap pattern in konzo – a non-progressive spastic para/tetraparesis of acute onset. Disabil Rehabil 2001;23:731–736.
7.
Banea M, Tylleskär T, Nahimana G, Nunga M, Gebre-Medhin M, Rosling H: Geographical and seasonal association between linamarin and cyanide exposure from cassava and the upper motor neuron disease konzo in Zaire. Trop Med Int Health 1997;2:1143–1151.
8.
Tylleskär T, Howlett W, Rwiza H, Aquilonious S-M, Stålberg E, Lindén B, Mandahl A, Larsen HC, Brubaker GR, Rosling H: Konzo: A distinct disease entity with selective upper motorneuron damage. J Neurol Neurosurg Psychiatry 1993;56:638–643.
9.
Tshala-Katumbay D, Mutombo-Lukusa V, Edebol Eeg-Olofsson K: EEG findings in konzo: A spastic para/tetraparesis of acute onset. Clin Electroencephalogr 2000;31:196–200.
10.
Tshala-Katumbay D, Edebol Eeg-Olofsson K, Kazadi-Kayembe T, Fällmar P, Tylleskär T, Kayembe-Kalula T: Abnormalities of somatosensory evoked potentials in konzo – an upper motor neuron disorders. Clin Neurophysiol 2002;113:10–15.
11.
Tshala-Katumbay D, Edebol Eeg-Olofsson K, Kazadi-Kayembe T, Tylleskär T, Fällmar P: Analysis of motor pathway involvement in konzo using transcranial electrical and magnetic stimulation. Muscle Nerve 2002;25:230–235.
12.
Mwanza J-C, Tshala-Katumbay D, Kayembe D, Eeg-Olofsson K, Tylleskär T: Neuro-ophthalmologic findings in konzo, an upper motor neuron disorder in Africa. Eur J Ophthalmol, in press.
13.
WHO: Konzo, a distinct type of upper motorneuron disease. Wkly Epidemiol Rec 1996;71:225–232.
14.
Misra U, Kalita J: Clinical Neurophysiology: Nerve Conduction, Electromyography and Evoked Potentials. New Delhi, Churchill Livingstone, 1999.
15.
Riemslag F, Spekreijse H, Van Wessen T: Responses to paired onset stimuli: Implications for the delayed evoked potentials in multiple sclerosis. Electroencephalogr Clin Neurophysiol 1985;62:155–166.
16.
Seki K, Nakasato N, Fujita S, Hatanaka K, Kawamura T, Kanno A, Yoshimoto T: Neuromagnetic evidence that the P100 component of the pattern reversal visual evoked response originates in the bottom of the calcarine fissure. Electroencephalogr Clin Neurophysiol 1996;100:436–442.
17.
Brecelj J, Kakigi R, Koyama S, Hoshiyama M: Visual evoked magnetic responses to central and peripheral stimulation: Simultaneous VEP recordings. Brain Topogr 1998;10:227–237.
18.
Shigeto H, Tobimatsu S, Yamamoto T, Kobayashi T, Kato M: Visual evoked cortical magnetic responses to checkerboard pattern reversal stimulation: A study on the neural generators of N75, P100 and N145. J Neurol Sci 1998;156:186–194.
19.
Hugon J, Ludolph A, Spencer P: β-N-Oxalylamino-1-alanine; in Spencer P, Schaumberg HH, Ludolph A (eds): Experimental and Clinical Neuro-Toxicology, ed 2. Oxford, Oxford University Press, 2000, pp 925–937.
20.
Donaghy M: Classification and clinical features of motor neurone diseases and motor neuropathies in adults. J Neurol 1999;246:331–333.
21.
Sawhney IM, Bansal SK, Upadhyay PK, Chopra JS: Evoked potentials in hereditary spastic paraplegia. Ital J Neurol Sci 1993;14:425–428.
22.
Panegyres PK, Purdie GH, Hamilton-Bruce MA, Rischbieth RH: Familial spastic paraplegia: An electrophysiological study of central sensory conduction pathways. Clin Exp Neurol 1991;28:97–111.
23.
Munte TF, Troger MC, Nusser I, Wieringa BM, Johannes S, Matzke M, Dengler R: Alteration of early components of the visual evoked potential in amyotrophic lateral sclerosis. J Neurol 1998;245:206–210.
24.
Matheson JK, Harrington HJ, Hallett M: Abnormalities of multimodality evoked potentials in amyotrophic lateral sclerosis. Arch Neurol 1986;43:338–340.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.